Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers

Biochemical Pharmacology

Volumn 55, Issue 4, 1998, Pages 387-395

  Sadphati, Laurent ^a   Benet, Leslie Z ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CYP3A; Dexamethasone; Gender; Induction; P glycoprotein; Rat liver

Indexed keywords

16ALPHA CYANOPREGNENOLONE; CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; GLYCOPROTEIN P; MESSENGER RNA; RIFAMPICIN; TROLEANDOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; ATP-BINDING CASSETTE TRANSPORTERS; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; ENZYME INDUCTION; FEMALE; GENE EXPRESSION; LIVER; MALE; OXIDOREDUCTASES, N-DEMETHYLATING; P-GLYCOPROTEIN; P-GLYCOPROTEINS; PREGNENOLONE CARBONITRILE; RATS; RATS, SPRAGUE-DAWLEY; RIFAMPIN; RNA, MESSENGER; SEX CHARACTERISTICS; TROLEANDOMYCIN;

EID: 0032519643     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00436-X     Document Type: Article

References (45)

1. Benet LZ, Kroetz DL and Sheiner LB, The dynamics of drug absorption, distribution, and elimination. In: Goodman & Gilman's The Pharmocological Basis of Therapeutics (Eds. Hardman JG and Limbird LE), pp. 3-27. McGraw-Hill, New York, 1996.
2. Kolars JC, Lown KS, Schmiedlin RP, Ghosh M, Fang C, Wrighton SA, Merion RM and Watkins PB, CYP3A gene expression in human gut epithelium. Pharmacogenetics 4: 247-259, 1994.
3. Leveille WC and Arias IM, The biology of the P-glycoproteins. J Membr Biol 143: 89-102, 1995.
4. Chin KV, Pastan I and Gottesman MM, Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60: 157-180, 1993.
5. Gottesman MM and Pastan I, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
6. Borst P, Schinkel AH, Smit JJ, Wagenaar E, van Deemter L, Smith AI, Eijdems EW, Baas F and Zaman GJ, Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol Ther 60: 289-299, 1993.
7. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR and Melamed MR, Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38: 1277-1287, 1990.
8. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CAAM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Berns AJM and Borst P, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77: 491-502, 1994.
9. Silverman JA and Thorgeirsson SS, Regulation and function of the mtiltidrug resistance genes in liver. In: Progress in Liver Diseases (Eds. Boyer JL and Ockner RK), pp. 101-123. W. B. Sanders, Philadelphia, 1995.
10. Ruetz S and Gros P, Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77: 1071-1081, 1994.
11. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, van Deemter L, Mol CAAM, Ottenhoff R, van der Lugt NMT, van Roon MA, van der Valk MA, Offerhaus GJA, Berns AJM and Borst P, Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75: 451-462, 1993.
12. Wacher VJ, Wu CY and Benet LZ, Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 13: 129-134, 1995.
13. Fardel O, Lecureur V and Guillouzo A, Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes. FEBS Lett 327: 189-193, 1993.
14. Schuetz JD, Silverman JA, Thottassery JV, Furuya KN and Schuetz EG, Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids. Cell Growth Differ 6: 1321-1332, 1995.
15. Zhao JY, Ikeguchi M, Eckersberg T and Kuo MT, Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology 133: 521-528, 1993.
16. Thorgeirsson SS, Gant TW and Silverman JA, Transcriptional regulation of multidrug resistance gene expression. In: Anticancer Drug Resistance: Advances in Molecular and Clinical Research (Eds. Goldstein LJ and Ozols RF), pp. 57-68. Kluwer Academic, Boston, 1994.
17. Burt RK and Thorgeirsson SS, Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics. J Natl Cancer Inst 80: 1383-1386, 1988.
18. Thorgeirsson SS, Silverman JA, Gant TW and Marino PA, Multidrug resistance gene family and chemical carcinogens. Pharmocol Ther 49: 283-292, 1991.
19. Schuetz EG, Beck WT and Schuetz JD, Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Moi Pharmocol 49: 311-318, 1996.
20. Guengerich FP, Analysis and characterization of enzymes. In: Principles and Methods of Toxicology (Ed. Hayes AW), pp. 777-814. Raven Press, New York, 1989.
21. Brown PC, Thorgeirsson SS and Silverman JA, Cloning and regulation of the rat mar2 gene. Nucleic Acids Res 21: 3885-3891, 1993.
22. Hod Y, A simplified ribonuclease protection assay. Biotechniques 13: 852-854, 1992.
23. Wrighton SA, Schuetz EG, Watkins PB, Maurel P, Barwick J, Bailey BS, Hartle HT, Young B and Guzelian P, Demonstration in multiple species of inducible hepatic cytochromes P-450 and their mRNAs related to the glucocorticoid-inducible cytochrome P-450 of the rat. Mol Pharmocol 28: 312-321, 1985.
24. Lee CH, Bradley G, Zhang JT and Ling V, Differential expression of P-glycoprotein genes in primary rat hepatocyte culture. J Cell Physiol 157: 392-402, 1993.
25. Brown RS Jr, Lomri N, De Voss J, Rahmaoui CM, Xie MH, Hua T, Lidofsky SD and Scharschmidt BF, Enhanced secretion of glycocholic acid in a specially adapted cell line is associated with overexpression of apparently novel ATP-binding cassette proteins. Proc Natl Acad Sci USA 92: 5421-5425, 1995.
26. Cooper KO, Reik LM, Jayyosi Z, Bandiera S, Kelley M, Ryan DE, Daniel R, McCluskey SA, Levin W and Thomas PE, Regulation of two members of the steroid-indicible cytochrome P450 subfamily (3A) in rats. Arch Biochem Biophys 301: 345-354, 1993.
27. Waxman DJ, Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochem Phormocol 37: 71-84, 1988.
28. Greenberger LM, Williams SS and Horwitz SB, Biosynthesis of heterogeneous forms of multidrug resistance-associated glycoproteins. J Biol Chem 262: 13685-13689, 1987.
29. Greenberger LM, Williams SS, Georges E, Ling V and Horwitz SB, Electrophoretic analysis of P-glycoproteins produced by mouse J774.2 and Chinese hamster ovary multidrug-resistant cells. J Natl Cancer Inst 80: 506-510, 1988.
30. Ichikawa M, Yoshimura A, Furukawa T, Sumizawa T, Nakazima Y and Akiyama S, Glycoiylation of P-glycoprotein in a multidrug-resistant KB cell line, and in the human tissues. Biochim Biophys Acta 1073: 309-315, 1991.
31. Yoshimura A, Kuwazuru Y, Sumizawa T, Ichikawa M, Ikeda S, Uda T and Akiyama S, Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. J Biol Chem 264: 16282-16291, 1989.
32. Daujat M, Pichard L, Fabre I, Pineau T, Fabre G, Bonfils C and Maurel P, Induction protocols for cytochromes P450IIIA in vivo and in primary cultures of animal and human hepatocytes. Methods Enzymol 206: 345-353, 1991.
33. Larsen MC and Jefcoate CR, Phenobarbital induction of CYP2B1, CYP2B2, and CYP3A1 in rat liver: genetic differences in a common regulatory mechanism. Arch Biochem Biophys 321: 467-476, 1995.
34. Hill BA, Brown PC, Preisegger K-H and Silverman JA, Regulation of mdr1b gene expression in Fischer, Wistar and Sprague-Dawley rats in vivo and in vitro. Carcinogenesis 17: 451-457, 1996.
35. Teeter LD, Estes M, Chan JY, Atassi H, Sell S, Becker FF and Kuo MT, Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol Carcinog 8: 67-73, 1993.
36. Lee CH, Bradley G and Ling V, Overexpression of the class II P-glycoprotein gene in primary rat hepatocyte culture: evidence for increased mRNA stability. Cell Growth Differ 6: 347-354, 1995.
37. Nakatsukasa H, Silverman JA, Gant TW, Evarts RP and Thorgeirsson SS, Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hefxaafogy 18: 1202-1207, 1993.
38. Schrenk D, Gant TW, Preisegger KH, Silverman JA, Marino PA and Thorgeirsson SS, Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 17: 854-860, 1993.
39. Gant TW, O'Connor CK, Corbitt R, Thorgeirsson U and Thorgeirsson SS, In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. Toxicol Appl Pharmacol 133: 269-276, 1995.
40. Chianale J, Vollrath V, Wielandt AM, Amigo L, Rigotti A, Nervi F, Gonzalez S, Andrade L, Pizarro M and Accatino L, Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochem J 314: 781-786, 1996.
41. Furuya KN, Gebhardt R, Schuetz EG and Schuetz JD, Isolation of rat pgp3 cDNA: evidence for gender and zonal regulation of expression in the liver. Biochim Biophys Acta 1219: 636-644, 1994.
42. Schuetz EG, Furuya KN and Schuetz JD, Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 275: 1011-1018, 1995.
43. Bradley G, Georges E and Ling V, Sex-dependent and independent expression of the P-glycoprotein isoforms in Chinese hamster. J Cell Physiol 145: 398-408, 1990.
44. Bames KM, Dickstein B, Cutler GJ, Fojo T and Bates SE, Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 35: 4820-4827, 1996.
45. Mode A, Norstedt G, Simic B, Eneroth P and Gustafsson JA, Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat. Endocrinology 108: 2103-2108, 1981.